| Tacrolimus hydrate (JP16) |
| Methotrexate (JP16/USP/INN) |
| Auranofin (JP16/USAN/INN) |
| Azathioprine (JP16/USP/INN) |
| Cyclophosphamide hydrate (JP16) |
| Salazosulfapyridine (JP16) |
| Penicillamine (JAN/USP/INN) |
| Etanercept (genetical recombination) (JAN) |
| Leflunomide (JAN/USAN/INN) |
| Sodium aurothiomalate (JP16) |
| Iguratimod (JAN/INN) |
| Mizoribine (JP16/INN) |
| Actarit (JAN/INN) |
| Lobenzarit sodium (JP16/USAN) |
| Bucillamine (JP16/INN) |
| Methotrexate sodium |
| Tocilizumab (genetical recombination) (JAN) |
| Adalimumab (genetical recombination) (JAN) |
| Infliximab (genetical recombination) (JAN) |
| Azathioprine sodium (USP) |
| Abatacept (genetical recombination) (JAN) |
| Certolizumab pegol (genetical recombination) (JAN) |
| Golimumab (genetical recombination) (JAN) |
| Cyclophosphamide (INN) |
| Penicillamine hydrochloride |
| Tacrolimus (INN) |
| Ofatumumab (genetical recombination) (JAN) |
| Tofacitinib citrate (JAN/USAN) |
| Secukinumab (USAN/INN) |
